Exclusive Program Designed to Help Startups Quickly Scale
SAN DIEGO—January 26, 2023—Faro Health, a leading company using technology to improve protocol design and eliminate operational errors and inefficiencies in clinical trials, was inducted into Microsoft for Startups, a global program dedicated to accelerating the trajectory of high-potential startups to enable growth at scale. As a program member, Faro Health now has exclusive access to Microsoft technology, mentorship, and business support as the company advances its cloud platform helping teams collaboratively design clinical protocols that balance the scientific needs of complex clinical development with the key drivers of performance, feasibility, and patient centricity.
Launched in 2019 in the Microsoft environment, Faro Health’s proprietary cloud-based platform is already helping a variety of enterprise-scale pharmaceutical and biotech companies to collaboratively develop and author complex clinical studies efficiently while using digital data flow to automate downstream processes. Faro’s platform ensures teams can collaboratively make informed decisions about the impact of every study activity and its associated measurement. Intuitive real time Insights powered by real word dataassist teams to adopt modern decentralized approaches. With visualizations of the patient journey always available, teams can focus on developing protocols that are more inclusive and patient centric.
Faro Health will use Microsoft technologies to reach a wide-scale audience in a short time. With built-in redundancy and security, as well as being guided by Azure’s Well-Architected Framework, Faro Health will also benefit from greater access to the powerful Microsoft Developer tools and exclusive wide-range programming support that help scale sales, marketing, business, and technological innovation faster and smarter.
“Faro Health is honored to be among such a select group of companies from around the world chosen to join the Microsoft for Startups program, and we plan to leverage this opportunity to its fullest,” said Scott Chetham, Co-Founder and CEO of Faro Health. “Our participation in the program comes at a critical time for our company as we launch new offerings for customers. Finding partners like Microsoft has been a key success factor for us at Faro as we drive the digital transformation of clinical development.”
About Faro Health
Faro Health redefines how clinical protocols are developed by connecting all the stakeholders in the clinical trials ecosystem, including sponsor and CRO ClinOps teams, research sites, vendors, patients, and laboratories through a single software platform. The Faro platform provides a best-in-class standardized library of study activities that has been augmented with performance-related real world data to provide intuitive insights during protocol development. Faro brings balance, centricity and flexibility to protocol development through detailed analysis of the impact of each study activity, ensuring teams have the optimum protocol design for operationally complex trials. As a result, clinical protocols developed using Faro’s Smart Designer platform are operationally efficient in answering the right questions in the least burdensome way for patients, payers, and regulators. Sponsors, CROs, and researchers can learn more by visiting www.farohealth.com and requesting a consultation with a Faro solutions expert.
Faro Health, Inc. is excited to announce that we have completed a Service Organization Control Type 2 (SOC 2 Type 2) examination by Sensiba San Filippo LLP (SSF). Founded in 2019, the Faro team worked tirelessly to develop and adhere to best-in-class compliance training programs that fit customers’ needs. Underlying all of this is Faro’s powerful technology platform which makes using Faro’s platform a seamless experience for administrators. It also means that customers trust Faro Health with their data, and at Faro we take that responsibility seriously. That’s why at Faro we build everything with security top of mind, and continue to invest heavily in securing our products, data, and business processes.
As SSF stated: “We are excited to announce that Faro Health Inc. has successfully completed a System and Organization Controls (SOC) 2 Type II audit, performed by Sensiba San Filippo, LLP (SSF). Developed by the American Institute of Certified Public Accountants (AICPA), the SOC 2 information security standard is an audit report on the examination of controls relevant to the trust services criteria categories covering security, availability, processing integrity, confidentiality and privacy. A SOC 2 Type II report describes a service organization’s systems and whether the design of specified controls meets the relevant trust services categories, and assesses the effectiveness of those controls over a specified period of time. Faro Health Inc’’s SOC 2 Type II report did not have any noted exceptions and therefore was issued with a “clean” audit opinion from SSF.”
Faro appreciates our partners at Drata, who helped simplify the audit process and allow us to monitor our compliance continuously. As it has done from the day it was founded, Faro will continue to follow secure procedures and industry best practices to assure software compliance and the safety of our customer data
Our SOC 2 Type 2 report is available to existing customers and prospects upon request (subject to confidentiality obligations). Reach out to your sales representative if you are interested in reviewing this report!
Set up a time to meet with us so that you can give your team the tools they deserve.